Related Experiment Video
Updated: Aug 30, 2026
Noninvasive Determination of Vortex Formation Time Using Transesophageal Echocardiography During Cardiac Surgery
Published on: November 28, 2018
Gender differences in the outcome of noninvasive cardiovascular treatment
Maria Penco1, Simona Fratini, Silvio Romano
1Division of Cardiology, Department of Internal Medicine and Public Health, University of L'Aquila, L'Aquila. mpenco@libero.it
Insights
Cardiovascular disease (CVD) affects both sexes, but women face worse outcomes post-myocardial infarction due to diagnostic challenges and socioeconomic factors. Understanding estrogen
Area of Science:
- Cardiology and Women's Health
Background:
- Cardiovascular diseases (CVDs) affect both sexes, with distinct pathogenesis, presentation, and outcomes.
- Incidence of CVDs rises in women post-menopause, linked to risk factors and female hormone interactions.
- Women experience poorer prognoses after myocardial infarction due to diagnostic difficulties and socioeconomic factors.
Purpose of the Study:
- To investigate the pathophysiology of atherosclerosis in women.
- To improve primary prevention, diagnostic, and therapeutic strategies for cardiovascular diseases in women.
Main Methods:
- Review of current literature on sex differences in cardiovascular disease.
- Analysis of risk factors, hormonal influences, and diagnostic challenges in women.
- Evaluation of hormone replacement therapy's role and risks.
Main Results:
- Diagnosis of myocardial infarction is more challenging in women (atypical symptoms, unclear ECG).
- Hormone replacement therapy's role in atherosclerosis prevention remains unclear, with associated risks (breast cancer, cardiovascular events).
- Biological mechanisms of estrogen deficiency in atherosclerosis development are not fully understood.
Conclusions:
- Primary prevention and pharmacological therapy are key for managing CVDs.
- Further research into the pathophysiology of atherosclerosis in women is crucial.
- Improved understanding will enhance prevention and treatment strategies for female cardiovascular health.
Abstract:
Cardiovascular diseases are equally common in both sexes with differences in pathogenesis, clinical presentation and outcome. The incidence of cardiovascular diseases progressively increases in women after the menopause and their development is related to risk factors and their interaction with the female hormones. The prognosis after myocardial infarction is worse in women because of a more difficult diagnosis (atypical symptoms, unclear ECG abnormalities) and because of social and economic factors. The role of hormone replacement therapy in atherosclerosis prevention is not yet clear, and there are many doubts about its administration because of the increased risk of breast cancer and cardiovascular events. Our best weapons against cardiovascular diseases are primary prevention and pharmacological therapy. The biological and pathophysiological mechanisms related to estrogen deficiency that may lead to the development of atherosclerosis are still unknown. Therefore, it would be useful to investigate the pathophysiology of atherosclerosis in women in order to improve primary prevention and the diagnostic and therapeutic strategies.
